The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.

Johnson & Johnson (J&J) has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety ...

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...

Amsterdam, Netherlands – 27 Aug 2023: Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ ...

During pulsed field ablation (PFA) for atrial fibrillation (Afib or AF), the additional creation of mitral isthmus ablation lines often led to vasospasm of the neighboring left circumflex artery, ...

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System The Sphere-360 catheter was ...

In April, we reported on a study that raised alarms for safety issues with pulsed field ablation for atrial fibrillation. In this report, we follow up on subsequent developments for this technology.

Johnson & Johnson (NYSE:JNJ) announced today that it launched the Varipulse Pro system in Europe following CE mark approval.